--- the subscriber area has no ads and those above are not selected or endorsed by this site ---


Akoustis 2Q23 schedule, Chargepoint battery development & more +3

09:23 31-Jan-23


Akoustis has scheduled the report on its fiscal second quarter for the morning of February 7th.  The average of 5 analyst estimates is a loss of 25 cents per share from $5.9M of revenue, ramping to $7.9M this quarter.  I've missed out on the post-dilution rebound in AKTS and am content with that, as I still see the shares as vulnerable, and mass manufacturing as deceptively difficult.

Chargepoint has also announced what sounds like a joint development agreement with Stem, a Fluence competitor that I've discussed with subscribers over the years.  ChargePoint will evaluate incorporating Stem's battery and networked software platform at new fast charging sites across the U.S.  I can personally attest to the power of time-shifted on-site solar plus charging, and like that ChargePoint will be taking advantage of the NEVI program, which provides $1b in funds per year from 2022 through 2026 for such non-proprietary development.  State by state plans can be found here.  I see this as another good step toward expanding service revenue for ChargePoint and will listen for details in both the Stem call in two weeks, and the next ChargePoint report, due at the beginning of March.  This doesn't make me want to add to my CHPT position at rebounded prices, though.

I'll also note that LUMN bear UBS lowered its price target from $7 to $5 yesterday.

Last and least, is yet another Vuzix deployment, this time down to the (third) warehouse level.